Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New medicines at risk from biodiversity loss

17.10.2003


Science study reveals that habitat loss imperil one of the world’s most promising source of new drugs



In a letter published in the October 17th issue of Science, three scientists warn that biodiversity loss could have devastating consequences for drug discovery and the development of new medicines. "Tropical cone snails may contain the largest and most clinically important pharmacopoeia of any genus in Nature" says lead author of the study, Eric Chivian from the Harvard Medical School, "but wild populations are being decimated by habitat destruction and overexploitation. To lose these species would be a self-destructive act of unparalleled folly."

Approximately 500 species of cone snails inhabit shallow tropical seas. They defend themselves and paralyze their prey – worms, fish, and other molluscs – by injecting a cocktail of toxins through a hollow, harpoon-like tooth. Each species has its own distinct set of around 100 ’conotoxins’, which like a gourmet chef it mixes in constantly changing proportions, thereby preventing evolution of resistance in their prey. Co-researcher Aaron Bernstein, also of Harvard, says "To date, only about 100 of the estimated 50,000 cone snail toxins have been characterized, and only a handful tested for pharmacologic activity. The results have extraordinary promise for the development of powerful new drugs."


With more than 2600 studies published in the last 20 years, there is much excitement about conotoxins in biomedicine. "Most conotoxins are a succinct ten to forty amino acids in length and are exquisitely selective about their receptor binding sites. This makes them powerful tools for understanding how cells work and a rich source for discovery of new medicines", said Bernstein. Among many discoveries, conotoxins that block key neurological pathways have been effective in the early detection and may also help treat small-cell lung cancer, one of the most devastating human cancers. A compound now in clinical trials has powerful anti-epileptic activity. Experiments suggest that conotoxins could treat muscle spasticity following spinal cord injury. They could prevent cell death when there is inadequate circulation, such as during strokes, head injuries or coronary bypass surgery. They could also be used to treat clinical depression, heart arrhythmias and urinary incontinence.

Conotoxin research has advanced farthest in treatment of pain. The synthetic drug Prialt is in extended Stage III clinical trials for the treatment of intractable pain (unremitting, severe, and essentially untreatable pain) and could soon be on the market. "Prialt may be 1000 times more potent than morphine. More importantly, it does not seem to lead to addiction or tolerance, where increasing doses are required to achieve the same effect" said Chivian. These problems have greatly limited the long-term effectiveness of the current mainstays of severe pain therapy, morphine and other opiates. Many millions of people suffer from intractable pain and have developed tolerance to opiates, so a potent painkiller like Prialt could represent an enormous therapeutic breakthrough.

Just as we are appreciating the remarkable potential of cone snails as a source of new medicines, they are coming under intense pressure in the wild. Their shallow tropical habitats are rapidly being destroyed and snails are being collected at alarming rates from the wild to supply the ornamental shell trade as well as for biomedical research.

Cone snails are exquisitely beautiful and have been coveted by collectors since at least the 16th Century. A rare cone snail shell was sold at an Amsterdam auction in 1796 for more than a Vermeer painting! Collectors still cherish these shells, and rates of capture from the wild are escalating rapidly. "Millions of cone snails are now sold annually for as little as a few cents each in shops all over the world. But we could not find any country that monitors this trade" said co-author Callum Roberts, of the University of York, "Nobody is looking out for them."

Alongside overexploitation, cone snail habitats are being degraded and destroyed by coastal development, overfishing, pollution, disease and global climate change. A quarter of the planet’s coral reefs have already been seriously damaged or destroyed and half of the world’s mangroves cleared. The risk of global extinction is highest for species with narrow geographic distributions. The study found that one in five cone snail species had global ranges encompassing less than 3500km2 of reef, equivalent to a single medium sized atoll. For example, eight species are unique to the Philippines, the hub of the world’s ornamental shell trade. People threaten 97% of Philippine coral reefs and extinctions are inevitable if impacts are not alleviated soon.

Habitat loss and escalating, uncontrolled exploitation make a lethal combination that today threatens with extinction cone snails and many other species of biomedical interest. "International markets can develop rapidly in the modern world, which means that wild populations can be decimated before regulatory agencies see any need to protect them." said Roberts. "For this reason, we believe all internationally traded organisms (whether alive or dead) must be monitored, regardless of whether they are currently listed as threatened. This would allow countries to identify emerging markets and act early enough to prevent depletion." This could be achieved, say the authors, by extending CITES (The Convention on International Trade in Endangered Species) to cover all wild-caught species. Meanwhile, at the earliest opportunity cone snails should be added to Appendix II of CITES, so requiring countries to monitor trade and prevent overexploitation.

"Wild nature has been the template for most of the medicines we use today but we have barely even begun to tap its potential", said Chivian, "If we fail to protect cone snails, the loss to future generations would be incalculable."


For More Information Contact:

Kathleen Frith, Director of Communications, HMS Center for Health and the Global Environment, Harvard Medical School, Boston, USA. Tel: 617-384-8591, kfrith@hms.harvard.edu

Callum Roberts, Professor of Marine Conservation, University of York, UK. Tel: 44-190-443-4066, Mobile 44-772-936-9303, email: cr10@york.ac.uk.

Kathleen Frith | EurekAlert!

More articles from Ecology, The Environment and Conservation:

nachricht Bioinvasion on the rise
15.02.2017 | Universität Konstanz

nachricht Litter Levels in the Depths of the Arctic are On the Rise
10.02.2017 | Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung

All articles from Ecology, The Environment and Conservation >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Breakthrough with a chain of gold atoms

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport

Im Focus: DNA repair: a new letter in the cell alphabet

Results reveal how discoveries may be hidden in scientific “blind spots”

Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...

Im Focus: Dresdner scientists print tomorrow’s world

The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.

The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...

Im Focus: Mimicking nature's cellular architectures via 3-D printing

Research offers new level of control over the structure of 3-D printed materials

Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...

Im Focus: Three Magnetic States for Each Hole

Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".

Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Booth and panel discussion – The Lindau Nobel Laureate Meetings at the AAAS 2017 Annual Meeting

13.02.2017 | Event News

Complex Loading versus Hidden Reserves

10.02.2017 | Event News

International Conference on Crystal Growth in Freiburg

09.02.2017 | Event News

 
Latest News

Stingless bees have their nests protected by soldiers

24.02.2017 | Life Sciences

New risk factors for anxiety disorders

24.02.2017 | Life Sciences

MWC 2017: 5G Capital Berlin

24.02.2017 | Trade Fair News

VideoLinks
B2B-VideoLinks
More VideoLinks >>>